Technical Comparison
Spyre Therapeutics, Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between SYRE and NVDA.
Primary Asset
SYR
Spyre Therapeutics, Inc. - Common Stock
Market Rank #1004693Live Price$97.87
Market Capitalization$8.5B
24h Change-2.09%
Circulating Supply87M SYRE
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$190.01
Market Capitalization$4.6T
24h Change-3.55%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | SYRE Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1004693 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $97.87 | $190.01 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $8.5B | $4.6T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Spyre Therapeutics, Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
Spyre Therapeutics, Inc. - Common Stock has a market cap of $8.5B, while NVIDIA Corporation - Common Stock sits at $4.6T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Spyre Therapeutics, Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 SYRE is worth 0.52 NVDA.